Major Hospitals Open Longevity Clinics, and STAT Asks Whether They Work

The Arising H E A L T H I N T E L L I G E N C E SUNDAY, OCTOBER 18, 2026 · MARKETS & STRATEGY DESK IN THIS EDITION · MARKETS & STRATEGY 1 Major Hospitals Open Longevity Clinics, and STAT Asks Whether They Work 2 PPIC Projects California's 65-Plus Labor Force Will Reach 1.8 Million by 2040 3 FDA Approves Viatris' Ryzumvi Eye Drops for Presbyopia in Adults 4 Wyden Seeks Input on Medicare or Medicaid Universal Home Care Benefit 5 Atrogi's Oral Muscle Drug Linked to 13% Power Gain in Small Study 6 Over 90% of US Nursing Homes Staff Below Acuity-Based Expected Level, LTCCC Says MARKETS & STRATEGY · WEEKLY READ · 2 MIN COMPETITIVE LANDSCAPE · STAT Major Hospitals Open Longevity Clinics, and STAT Asks Whether They Work Large hospitals are now opening longevity clinics, according to STAT, which asks a basic question about them: what are people paying for, and does it work? The page we reviewed does not state prices or payment terms, and it offers no evidence that the services work. ccording to STAT, longevity clinics are popping up in major hospitals across the country. STAT's biotech podcast, The Readout LOUD, devoted its Oct. 16A episode to the trend. The hosts are Elaine Chen, Adam Feuerstein and Allison DeAngelis. Their guest was STAT reporter Sarah Todd, who visited one of the clinics. The market is described as very large. STAT says longevity medicine is "estimated to be a multitrillion dollar industry." The episode page does not say who made that estimate or how it was calculated. Readers should treat the figure as an unverified claim. THE ARISING · OCTOBER 18, 2026 PAGE 25 STAT's page does not spell out why hospitals are entering this field, so we do not offer a view on their motives. STAT's headline for the episode calls longevity clinics "Hospitals' next lucrative bet." That is STAT's description, and it is a bet, not a proven result. The page does not name which clinic Todd visited, and it does not list the services offered or what patients pay. It points readers to a separate piece for more on her experience, which we did not have. The page's web address mentions Northwestern, but the text does not say where Todd went. We therefore make no claim about the institution, the tests or the cost. The competitive picture is largely unknown. The source does not provide data on how many clinics exist, what they earn, who else operates in the field, or how patients are choosing among providers. The central question is whether the services work. The episode asks, "what are people paying for, and does it work?" The page presents no evidence that any testing or program leads to longer life or better health. This is the weakest point in the whole story: a large market estimate with no stated source, and no outcome data. A clear answer would matter either way. If the programs show real benefit, hospitals may have found a durable new business line. If they do not, the model could invite scrutiny. Regulatory impact is not addressed in the STAT page. No rules, enforcement actions or oversight plans are described, so any view on that point would be speculation. Readers considering longevity testing or programs should consult a clinician before acting. WHAT TO WATCH NEXT Whether hospitals publish outcome data for these clinics, and whether STAT's follow-up reporting clarifies what the services are, what they cost and whether they work. Source: STAT THE ARISING · OCTOBER 18, 2026 PAGE 26